FIH urgency in the U.S. Plus: federated learning, biotech IPOs — a BioCentury podcast

• First-in-human trial competitiveness — Global pressure, especially from China, is forcing the U.S. to confront contracting, IRB and start-up inefficiencies that affect development speed and long-term competitive positioning

• Federated learning in drug discovery — Privacy-preserving data collaboration is becoming more practical in drug discovery, able to improve model performance without making users share crown-jewel datasets, and finding areas of high strategic value...